Targeting the P2Y13 Receptor Suppresses IL-33 and HMGB1 Release and Ameliorates Experimental Asthma.
Werder RB, Ullah MA, Rahman MM, Simpson J, Lynch JP, Collinson N, Rittchen S, Rashid RB, Sikder MAA, Handoko HY, Curren BF, Sebina I, Hartel G, Bissell A, Ngo S, Yarlagadda T, Hasnain SZ, Lu W, Sohal SS, Martin M, Bowler S, Burr LD, Martinez LO, Robaye B, Spann K, Ferreira MAR, Phipps S.
Werder RB, et al. Among authors: collinson n.
Am J Respir Crit Care Med. 2022 Feb 1;205(3):300-312. doi: 10.1164/rccm.202009-3686OC.
Am J Respir Crit Care Med. 2022.
PMID: 34860143